NCT03387917 2024-12-02TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid TumorsSwiss Cancer InstitutePhase 1 Terminated12 enrolled
NCT00819221 2022-08-30AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid TumoursAstraZenecaPhase 1 Terminated44 enrolled
NCT00859495 2020-08-25Trimodal Lung-Sparing Treatment of Pleural MesotheliomaColumbia UniversityPhase 2 Terminated9 enrolled 4 charts